177Lu-DOTA-TLX591
177Lu-TLX591-001
Phase 1 mab completed
Quick answer
177Lu-DOTA-TLX591 for Metastatic Prostate Cancer is a Phase 1 program (mab) at Telix Pharmaceuticals Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Telix Pharmaceuticals Ltd
- Indication
- Metastatic Prostate Cancer
- Phase
- Phase 1
- Modality
- mab
- Status
- completed